Balyasny Asset Management LLC Kymera Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$10.97 - $26.84 $248,766 - $608,650	22,677 New	22,677 $577,000
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $1.17 Million - $1.82 Million	52,043 New	52,043 $1.2 Million
Q3 2021 Nov 15, 2021	SELL	$47.8 - $66.66 $5.72 Million - $7.98 Million	-119,761 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $1.72 Million - $2.88 Million	55,451 Added 86.22%	119,761 $5.81 Million
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $2.29 Million - $5.5 Million	64,310 New	64,310 $2.5 Million

186

65.5M

49.6K

17K

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.01B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.